Biorelevant dissolution testing of St John's wort products

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 12, 2002, Pages 1615-1621

  Westerhoff, Kerstin ^a   Kaunzinger, Astrid ^a   Wurglics, Mario ^a   Dressman, Jennifer ^a   Schubert Zsilavecz, Manfred ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DRUG; FLAVONOID; HERBACEOUS AGENT; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; HYPERIN; ISOQUERCITRIN; LAIF; NAPHTHODIANTHRONE DERIVATIVE; PHLOROGLUCINOL DERIVATIVE; PLANT EXTRACT; QUERCITRIN; RUTOSIDE; TEXX; UNCLASSIFIED DRUG;

ARTICLE; CAT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG IDENTIFICATION; DRUG INDUSTRY; DRUG LABELING; DRUG SCREENING; DRUG SOLUBILITY; DRUG STRUCTURE; HERBAL MEDICINE; HYPERICUM PERFORATUM; NONHUMAN; PLANT;

ANTIDEPRESSIVE AGENTS; BICYCLO COMPOUNDS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOL; HYPERICUM; KINETICS; METHANOL; PHLOROGLUCINOL; PLANT EXTRACTS; QUERCETIN; REPRODUCIBILITY OF RESULTS; RUTIN; SOLUBILITY; SOLVENTS; TERPENES; TIME FACTORS;

EID: 0036907904     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702315     Document Type: Article

References (19)

1. Beckert, A., Quach, T. (1996) Improved hydrodynamics for USP. Dissolution Technologies 3: whole issue
2. Bundesanzeiger: Erläuterungen zum Antrag auf Zulassung eines Arzneimittels (Rdn. 681) (3. Auflage Stand: 31. Oktober 1996) im Bundesanzeiger Nr. 44a (49) 1997 ISSN 0720-6100
3. Butterweck, V., Jürgenliemk, G., Nahrstedt, A., Winterhoff, H. (2000) Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med. 66: 3-6
4. Dressman, J. B., Amidon, G. L., Reppas, C., Shah, V. P. (1998) Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms. Pharm. Res. 15: 11-22
5. EMEA (The European Agency for the Evaluation of Medicinal Products) (1999) Note for guidance on specifications: Test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products. http://www.eudra.org/emea.html (accessed June 2000)
6. FDA (1997) FDA guidance for industry: Dissolution of immediate release solid oral dosage forms. http://www.fda.gov/cder/guidance.html (accessed February 2001)
7. Galia, E., Nicolaides, E., Hörter, D., Löbenberg, R., Reppas, C., Dressman, J. B. (1998) Evaluation of various dissolution media for predicting in vivo performance of Class I and II drugs. Pharm. Res. 15: 698-670
8. Greeson, J. M., Sanford, B., Monti, D. A. (2001) St. John's wort: A review of the current pharmacological, toxicological and clinical literature. Psychopharmacology 153: 402-414
9. ICH Topic Q2A (1994) Step 5 note for guidance on validation of analytical methods: Definitions and terminology (CPMP/ICH/381/95 - adopted Nov. 94). http://www.emea.eu.int/pdfs/human/ich/038195en.pdf (accessed November 1999)
10. ICH Topic Q2B (1996) Step 4 note for guidance on validation of analytical procedures: Methodology (CPMP/ICH/281/95 - Adopted December 96). http:/www.emea.eu.int/pdfs/human/ich/028915en.pdf (accessed November 1999)
11. Lang, F., Stumpf, H. (1999) Considerations on future pharmacopoeial monographs for plant extracts. Pharmeuropa 11: 268-275
12. Michelitsch, A., Biza, B., Wurglics, M., Schubert-Zsilavecz, M., Baumeister, A., Likussar, W. (2000) Determination of hypericin in herbal medicine products by differential pulse polarography. Phytochem. Anal. 11: 41-44
13. Nahrstedt, A., Butterweck, V. (1997) Biologically active and other chemical constituents of herb of Hypericum perforatum L. Pharmacopsychiatry 30 (Suppl. 2): 129-134
14. Shah, V. (2001) Dissolution: A quality control test vs. a bioequivalence test. Dissolution Technologies 8: 6-7
15. Siewert, M. (1997) FIP guidelines for dissolution testing of solid oral products. Pharm. Ind. 59: 760-766
16. USP 25a 2040 Disintegration and Dissolution of Nutritional Supplements 2481-2483
17. USP 25b Test Solutions Gastric Fluid, Simulated, TS; 2344
18. Wonnemann, M., Singer, A., Müller, W. E. (2000) Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's wort: The role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology 23: 188-197
19. Wurglics, M., Westerhoff, K., Kaunzinger, A., Wilke, A., Baumeister, A., Dressmann, J. B., Schubert-Zsilavecz, M. (2001) Batch-to-batch reproducibility of St. John's wort preparations. Pharmacopsychiatry 34 (Suppl. 1): 152-156